Evidence map›Paper›PMID 18559526›Full record

ArticleCancer research2008

Glutathione s-transferase p1: gene sequence variation and functional genomic studies.

Ann M Moyer, Oreste E Salavaggione, Tse-Yu Wu, Irene Moon, Bruce W Eckloff, Michelle A T Hildebrandt, Daniel J Schaid, Eric D Wieben, Richard M Weinshilboum

Abstract read
In one paragraph

Article in Cancer research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Association of Polymorphisms inOxidative medicine and cellular longevity · 2021
    Article
  11. Medicina (Kaunas, Lithuania) · 2020
    Article
  12. Article
  13. Oncotarget · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Variants of glutathione s-transferase pi 1 exhibit differential enzymatic activity and inhibition by heavy metals.Toxicology in vitro : an international journal published in association with BIBRA · 2012
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ann M MoyerDivision of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Medical School-Mayo Clinic, Rochester, Minnesota, USA.
Oreste E Salavaggione
Tse-Yu Wu
Irene Moon
Bruce W Eckloff
Michelle A T Hildebrandt
Daniel J Schaid
Eric D Wieben
Richard M Weinshilboum
Laboratoire de Biochimie · FRMayo Clinic · USMayo Clinic in Florida · US

Funding

PHARMACOGENETICS OF PHASE II DRUG METABOLIZING ENZYMESU01GM061388 · NIGMS · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 2000 to 2009
$15.7M
INHERITED VARIATIONS IN DRUG-METABOLIZING ENZYMESR01GM028157 · NIGMS · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 1985 to 2019
$6.9M
Predoctoral Training Program in Molecular PharmacologyT32GM072474 · NIGMS · MAYO CLINIC ROCHESTER · PI KARNITZ, LARRY M · 2005 to 2020
$2.4M
SULFATE CONJUGATION AND DRUG METABOLISMR01GM035720 · NIGMS · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 1986 to 2007
$2.3M
NIGMS NIH HHS R01 GM028157NIGMS NIH HHS R01 GM035720NIGMS NIH HHS R01 GM28157NIGMS NIH HHS R01 GM35720NIGMS NIH HHS T32 GM072474NIGMS NIH HHS T32 GM72474NIGMS NIH HHS U01 GM061388NIGMS NIH HHS U01 GM61388
6 · The paper itself

Abstract

Glutathione S-transferase P1 (GSTP1) is of importance for cancer research because of its role in detoxifying carcinogens, activating antineoplastic prodrugs, metabolizing chemotherapeutic agents, and its involvement in cell cycle and apoptosis regulation. Two common GSTP1 genetic polymorphisms have been studied extensively. However, the full range of GSTP1 genetic variation has not been systematically characterized in the absence of disease pathology. We set out to identify common GSTP1 polymorphisms in four ethnic groups, followed by functional genomic studies. All exons, splice junctions, and the 5'-flanking region of GSTP1 were resequenced using 60 DNA samples each from four ethnic groups. The 35 single-nucleotide polymorphisms (SNP) identified included six nonsynonymous SNPs and 17 previously unreported polymorphisms. GSTP1 variant allozymes were then expressed in COS-1 cells, and five displayed significantly altered levels of enzyme activity. One decreased to 22% of the wild-type (WT) activity. Four variant allozymes had K(m) values that differed significantly from that of the WT, and five showed altered levels of immunoreactive protein compared with WT, with a significant correlation (r = 0.79, P < 0.007) between levels of immunoreactive protein and enzyme activity in these samples. In the Mexican American population, five linked SNPs were significantly associated with GSTP1 mRNA expression, one of which was found by electrophoretic mobility shift assay to alter protein binding. These studies have identified functionally significant genetic variation, in addition to the two frequently studied GSTP1 nonsynonymous SNPs, that may influence GSTP1's contribution to carcinogen and drug metabolism, and possibly disease pathogenesis and/or drug response.

Indexed as

Genetic VariationAnimalsBlotting, WesternChlorocebus aethiopsCOS CellsElectrophoretic Mobility Shift AssayEthnicityGene Expression ProfilingGenomicsGlutathione S-Transferase piHaplotypesHumansOligonucleotide Array Sequence AnalysisPolymorphism, Single NucleotideProtein BiosynthesisReverse Transcriptase Polymerase Chain ReactionGlutathione S-Transferase piGSTP1 protein, humanRNA, Messenger

Identifiers

PMID18559526
PMCPMC2490824
OpenAlexW2114327673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.